Skip to content

Clinical trials

Phase 2 Amyotrophic Lateral Sclerosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyotrophic Lateral Sclerosis Phase: Phase 2 Country / region: United States Clear all

88 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20031
20041
20054
20062
20083
20092
20101
20115
20123
20138
20142
20152
20164
20176
20186
20192
20207
20218
20223
20231
20242
20257
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59
Terminated10
Active, not recruiting7
Recruiting6
Withdrawn4
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cytokinetics5
Massachusetts General Hospital4
Novartis Pharmaceuticals4
Amylyx Pharmaceuticals Inc.2
Aquestive Therapeutics2
Barrow Neurological Institute2
Columbia University2
CytRx2
Duke University2
Helixmith Co., Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyotrophic Lateral Sclerosis88
Motor Neuron Disease13
Nervous System Diseases5
Neuromuscular Diseases5
Central Nervous System Diseases3
Neurodegenerative Diseases3
Anxiety Disorders2
Frontotemporal Dementia2
Mitochondrial Diseases2
Multiple Sclerosis2

Trials

Showing 1 to 25 of 88. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.